Captain's Quarters

[JD400]

Todays Booms & Bams 3-Downs CRME NAP CRDS



Ticker CRME [NASD]


Company Cardiome Pharma Corp.
Country Canada
Industry Drug Manufacturers - Other
Market Cap 133.71M EPS (ttm) -0.82
P/E - EPS this Y 42.20%
Forward P/E - EPS next Y 62.00%
PEG - EPS past 5Y 19.40%
P/S 5.76 EPS next 5Y 28.00%
P/B 4.35 EPS Q/Q 28.90%
Dividend - Sales Q/Q -1.70%
Insider Own 0.80% Inst Own 76.60%
Insider Trans 0.00% Inst Trans -0.21%
Short Float 0.93% Earnings Aug 08/a
Analyst Recom 2.00 Target Price 6.68
Avg Volume 93.81K 52W Range 2.35 - 4.84
Aug-21-17 08:00AM Cardiome Provides U.S. Regulatory Update For BRINAVESS PR Newswire
Aug-08-17 11:55PM Cardiome reports 2Q loss Associated Press
Aug-08-17 04:00PM Cardiome Reports Second Quarter 2017 Financial Results PR Newswire
Aug-08-17 10:40AM Investor Network: Cardiome Pharma Corp. to Host Earnings Call ACCESSWIRE
Aug-01-17 08:00AM Cardiome To Hold Second Quarter 2017 Financial Results Conference Call On August 8 CNW Group
Jul-17-17 08:00AM Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen PR Newswire
Jul-04-17 09:16AM Cardiome's Partner SteadyMed Submits NDA for PAH Injection Zacks
Jul-03-17 08:00AM Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension PR Newswire
Jun-23-17 08:00AM Cardiome Pharma Corp. Announces Voting Results PR Newswire
Jun-21-17 08:00AM Cardiome Announces Licensing Agreement for XYDALBA (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel PR Newswire


Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. It offers BRINAVESS (vernakalant (IV)) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; XYDALBA, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and TREVYENT for the treatment of pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx


Ticker NAP [NYSE]


Company Navios Maritime Midstream Partners L.P.
Country Monaco
Industry Shipping
Market Cap 168.39M EPS (ttm) 1.22
P/E 6.73 EPS this Y -13.20%
Forward P/E 9.36 EPS next Y 15.85%
PEG - EPS past 5Y -14.33%
P/S 1.83 EPS next 5Y -9.24%
P/B 0.64 EPS Q/Q -66.70%
Dividend 20.58% Sales Q/Q -18.40%
Insider Own - Inst Own 34.70%
Insider Trans - Inst Trans 0.62%
Short Float 1.61% Earnings Jul 26/b
Analyst Recom 3.30 Target Price 10.33
Avg Volume 94.45K 52W Range 8.21 - 12.70
Aug-21-17 07:37AM Maxim Group Just Cut Its Target Price for This Tanking Company Market Realist
Aug-18-17 09:07AM Euronav on the Street: Analyst Recommendations after the 2Q17 Results Market Realist
Aug-17-17 10:37AM Behind Euronavs New Fixed Dividend Policy Market Realist
Aug-16-17 04:13PM Inside Euronavs 2Q17 Results Market Realist
Aug-07-17 01:12PM Navios Maritime Midstream Partners LP :NAP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 7, 2017 Capital Cube
Aug-07-17 07:38AM Analysts Cut the Target Prices for NAP and NAT Market Realist
Aug-01-17 10:36AM J.P. Morgan Slashed Its Target Price for NAP after 2Q17 Results Market Realist
Aug-01-17 09:07AM Navios Maritime Midstream Partners Financial Health after Q2 Market Realist
Aug-01-17 07:37AM Navios Maritime Midstream Partners Distributions in 2Q17 Market Realist
Jul-31-17 10:37AM How Navios Maritime Midstream Partners Expenses Impacted Earnings Market Realist


Navios Maritime Midstream Partners L.P. owns, operates, and acquires crude oil tankers, refined petroleum product tankers, chemical tankers, and liquefied petroleum gas tankers. The company charters its vessels under long-term employment contracts to international oil companies, refiners, and large vessel operators. As of December 31, 2016, it owned six VLCC vessels. Navios Maritime Midstream Partners GP LLC operates as the general partner of the company. Navios Maritime Midstream Partners L.P. was founded in 2014 and is based in Monaco.

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx


Ticker CRDS [NASD]


Company Crossroads Systems, Inc.
Country USA
Industry Data Storage Devices
Market Cap 3.01M EPS (ttm) -1.08
P/E - EPS this Y 88.70%
Forward P/E - EPS next Y -
PEG - EPS past 5Y 43.90%
P/S 10.02 EPS next 5Y 20.00%
P/B 1.09 EPS Q/Q 76.40%
Dividend - Sales Q/Q -92.40%
Insider Own 2.70% Inst Own 33.10%
Insider Trans 0.00% Inst Trans -0.70%
Short Float 2.74% Earnings Sep 07/a
Analyst Recom 2.00 Target Price 75.00
Avg Volume 134.75K 52W Range 1.45 - 7.42
Aug-14-17 06:01PM Crossroads Systems, Inc. files Chapter 11 case and prepackaged plan of reorganization, announces new investor and access to capital for acquisitions PR Newswire
Aug-14-17 04:58PM [$$] Crossroads Systems Files for Bankruptcy in Pursuit of $4 Million Investor Deal The Wall Street Journal
Jun-14-17 08:15AM Earnings Highlights and Review: Pure Storage's Quarterly Revenue Jumped 31%; Net Loss Narrowed Accesswire
May-26-17 10:00AM Crossroads Systems, Inc. :CRDS-US: Earnings Analysis: Q2, 2017 By the Numbers : May 26, 2017 Capital Cube
May-25-17 04:03PM Crossroads Systems Reports Fiscal Second Quarter 2017 Financial Results PR Newswire
Mar-22-17 10:08AM Crossroads Systems, Inc. :CRDS-US: Earnings Analysis: Q1, 2017 By the Numbers : March 22, 2017 Capital Cube
Mar-10-17 04:05PM Crossroads Systems Reports Fiscal First Quarter 2017 Financial Results PR Newswire
Feb-27-17 08:54AM Edited Transcript of CRDS earnings conference call or presentation 2-Jun-16 8:30pm GMT Thomson Reuters StreetEvents
Jan-26-17 09:30AM Crossroads Systems, Inc. :CRDS-US: Earnings Analysis: 2016 By the Numbers : January 26, 2017 Capital Cube
Dec-13-16 04:05PM Crossroads Systems Reports Fiscal Fourth Quarter and Full Year 2016 Financial Results PR Newswire


Crossroads Systems, Inc. operates as an intellectual property licensing company. It develops storage industry's fundamental patents related to access controls. The company was founded in 1996 and is headquartered in Austin, Texas.

end